标题
Recent clinical trends in Toll-like receptor targeting therapeutics
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-11-19
DOI
10.1002/med.21553
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
- (2018) Lan Huang et al. Cellular & Molecular Immunology
- Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
- (2018) Kumar Vijay INTERNATIONAL IMMUNOPHARMACOLOGY
- Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study
- (2018) Philip E. Silkoff et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
- (2018) Harry L.A. Janssen et al. JOURNAL OF HEPATOLOGY
- The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
- (2018) Md Jakir Hossain et al. Frontiers in Immunology
- Toll-like receptors in COPD
- (2017) Philip M. Hansbro et al. EUROPEAN RESPIRATORY JOURNAL
- Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities
- (2017) Lei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small-molecule inhibition of TLR8 through stabilization of its resting state
- (2017) Shuting Zhang et al. Nature Chemical Biology
- Airway Mucin Concentration as a Marker of Chronic Bronchitis
- (2017) Mehmet Kesimer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy
- (2017) V Mett et al. ONCOGENE
- Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation
- (2017) Ilia A. Toshkov et al. RADIATION RESEARCH
- Why clinical trial outcomes fail to translate into benefits for patients
- (2017) Carl Heneghan et al. Trials
- Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
- (2017) Wei Gao et al. Frontiers in Physiology
- A conserved TLR5 binding and activation hot spot on flagellin
- (2017) Wan Seok Song et al. Scientific Reports
- Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier
- (2016) Patrick Vianna Garcia et al. BMC CANCER
- RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
- (2016) Pedro Barata et al. CANCER TREATMENT REVIEWS
- Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy
- (2016) Bradley J. Monk et al. CLINICAL CANCER RESEARCH
- Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
- (2016) E Monnet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Osteoimmunology and Beyond
- (2016) Lia Ginaldi et al. CURRENT MEDICINAL CHEMISTRY
- TLR7 Structure: Cut in Z-Loop
- (2016) Kazuhiko Maeda et al. IMMUNITY
- Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA
- (2016) Zhikuan Zhang et al. IMMUNITY
- Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma
- (2016) Keith Biggadike et al. JOURNAL OF MEDICINAL CHEMISTRY
- Toll-like receptors and chronic inflammation in rheumatic diseases: new developments
- (2016) Leo A. B. Joosten et al. Nature Reviews Rheumatology
- Autoinhibition and relief mechanism by the proteolytic processing of Toll-like receptor 8
- (2016) Hiromi Tanji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS
- (2016) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
- (2016) Thomas J. Hwang et al. JAMA Internal Medicine
- Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants
- (2016) Anna Pomerenke et al. International Journal of Chronic Obstructive Pulmonary Disease
- CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study
- (2015) T. B. Casale et al. ALLERGY
- Toll-Like Receptor 2 (TLR2) and TLR9 Play Opposing Roles in Host Innate Immunity against Salmonella enterica Serovar Typhimurium Infection
- (2015) Renhui Zhan et al. INFECTION AND IMMUNITY
- Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
- (2015) Umeharu Ohto et al. NATURE
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis
- (2015) Cristiano Xavier Lima et al. PLoS One
- Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
- (2015) Mark W. Julian et al. PLoS One
- Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation
- (2015) Wei Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics
- (2015) Elisabetta Pace et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines
- (2015) M. Karlsen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism
- (2015) Hua Yang et al. Oncotarget
- Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
- (2015) Manh-Cuong Vo et al. Oncotarget
- The TLR2 is activated by sporozoites and suppresses intrahepatic rodent malaria parasite development
- (2015) Hong Zheng et al. Scientific Reports
- Dendritic cell targeted vaccines: Recent progresses and challenges
- (2015) Pengfei Chen et al. Human Vaccines & Immunotherapeutics
- Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+T cells from allergic patients
- (2014) S. Deifl et al. ALLERGY
- TLRs: Linking inflammation and breast cancer
- (2014) Khyati Bhatelia et al. CELLULAR SIGNALLING
- Mycobacterium indicus praniiandMycobacterium bovisBCG lead to differential macrophage activation in Toll-like receptor-dependent manner
- (2014) Pawan Kumar et al. IMMUNOLOGY
- Safety of Toll-like receptor 9 agonists: a systematic review and meta-analysis
- (2014) Mei Qin et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- TLR Cross-talk Confers Specificity to Innate Immunity
- (2014) Rebecca S. T. Tan et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
- (2014) A. Ruzsa et al. INVESTIGATIONAL NEW DRUGS
- Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns
- (2014) Liliana Schaefer JOURNAL OF BIOLOGICAL CHEMISTRY
- Innate Immunity Mediated by TLR5 as a Novel Antiinflammatory Target for Cystic Fibrosis Lung Disease
- (2014) C. J. Blohmke et al. JOURNAL OF IMMUNOLOGY
- Imiquimod is not an effective drug for molluscum contagiosum
- (2014) Kenneth A Katz LANCET INFECTIOUS DISEASES
- Role of TLR5 and Flagella in Bacillus Intraocular Infection
- (2014) Salai Madhumathi Parkunan et al. PLoS One
- Human TLR10 is an anti-inflammatory pattern-recognition receptor
- (2014) Marije Oosting et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
- (2014) Nan Wang et al. Frontiers in Immunology
- Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension
- (2013) Cameron G. McCarthy et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The Second Messenger Phosphatidylinositol-5-Phosphate Facilitates Antiviral Innate Immune Signaling
- (2013) Takumi Kawasaki et al. Cell Host & Microbe
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
- (2013) M Reilly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Structure and dynamic behavior of Toll-like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols ofPlasmodium falciparum
- (2013) Prasannavenkatesh Durai et al. FEBS Journal
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
- (2013) Steven M. Opal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells
- (2013) I. Ioannidis et al. JOURNAL OF VIROLOGY
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands
- (2013) H. Tanji et al. SCIENCE
- Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle
- (2013) Pervaiz Dar et al. VACCINE
- Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
- (2013) Athina Savva et al. Frontiers in Immunology
- DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
- (2013) Traci L Hilton et al. Journal for ImmunoTherapy of Cancer
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
- (2012) Fatih Arslan et al. Circulation-Cardiovascular Interventions
- The Effects of TLR Activation on T-Cell Development and Differentiation
- (2012) Bo Jin et al. Clinical & Developmental Immunology
- Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
- (2012) Yi-Tzu Lin et al. CURRENT GENOMICS
- Adjuvants for human vaccines
- (2012) Carl R Alving et al. CURRENT OPINION IN IMMUNOLOGY
- Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
- (2012) Greg S Martin Expert Review of Anti-Infective Therapy
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Regulation of B-cell responses by Toll-like receptors
- (2012) Edward P. Browne IMMUNOLOGY
- TLR3 activation efficiency by high or low molecular mass poly I:C
- (2012) Yu Zhou et al. Innate Immunity
- IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis
- (2012) Christophe Cataisson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
- (2012) Mauricio A. Arias et al. PLoS One
- Human TLRs and IL-1Rs in Host Defense: Natural Insights from Evolutionary, Epidemiological, and Clinical Genetics
- (2011) Jean-Laurent Casanova et al. Annual Review of Immunology
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid A Augments Innate Host Resistance to Systemic Bacterial Infection
- (2011) Christopher D. Romero et al. INFECTION AND IMMUNITY
- Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface
- (2011) V. Y. Toshchakov et al. JOURNAL OF IMMUNOLOGY
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- Small-Molecule Inhibitors of the TLR3/dsRNA Complex
- (2011) Kui Cheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Direct, Noncatalytic Mechanism of IKK Inhibition by A20
- (2011) Brian Skaug et al. MOLECULAR CELL
- The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors
- (2011) Jae-Min Yuk et al. NATURE IMMUNOLOGY
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
- (2011) David N. Taylor et al. VACCINE
- Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
- (2011) Natarajan Muthusamy et al. Cancer Genetics
- Similar Structures but Different Roles – An Updated Perspective on TLR Structures
- (2011) Balachandran Manavalan et al. Frontiers in Physiology
- DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
- (2010) Nga N. Ta et al. ATHEROSCLEROSIS
- When failure should be the option
- (2010) Gregory A Petsko BMC BIOLOGY
- Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro
- (2010) Rachel A. Bunting et al. CELLULAR IMMUNOLOGY
- Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis
- (2010) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- Flagellin as an Adjuvant: Cellular Mechanisms and Potential
- (2010) S. B. Mizel et al. JOURNAL OF IMMUNOLOGY
- TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
- (2010) Kevin M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling
- (2010) Su-Chang Lin et al. NATURE
- Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b
- (2010) Chaofeng Han et al. NATURE IMMUNOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
- (2009) Matthijs Kox et al. BIOCHEMICAL PHARMACOLOGY
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
- Lipopolysaccharide-Trap-Fc, a Multifunctional Agent To Battle Gram-Negative Bacteria
- (2009) P. Gross et al. INFECTION AND IMMUNITY
- Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors
- (2009) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice
- (2009) Marie-Laure Santiago-Raber et al. JOURNAL OF AUTOIMMUNITY
- TLR Cross-Talk Specifically Regulates Cytokine Production by B Cells from Chronic Inflammatory Disease Patients
- (2009) M. Jagannathan et al. JOURNAL OF IMMUNOLOGY
- Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells
- (2009) S. M. Makela et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88–independent TLR4 pathway
- (2009) Eva M Palsson-McDermott et al. NATURE IMMUNOLOGY
- TLR3: Interferon induction by double-stranded RNA including poly(I:C)☆
- (2008) M MATSUMOTO et al. ADVANCED DRUG DELIVERY REVIEWS
- Protective Role of Toll-like Receptor 4 during the Initiation Stage of Cutaneous Chemical Carcinogenesis
- (2008) N. Yusuf et al. CANCER RESEARCH
- A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands
- (2008) David Dowling et al. CYTOKINE
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity
- (2008) Ulrich Zähringer et al. IMMUNOBIOLOGY
- Toll-Like Receptor 9-Dependent Immune Activation by Unmethylated CpG Motifs in Aspergillus fumigatus DNA
- (2008) Z. G. Ramirez-Ortiz et al. INFECTION AND IMMUNITY
- TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation
- (2008) Mude Shi et al. NATURE IMMUNOLOGY
- TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
- (2008) Jonathan C Kagan et al. NATURE IMMUNOLOGY
- The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
- (2008) E. L. J. M. Smits et al. ONCOLOGIST
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More